Stryker to Acquire Amplitude Vascular Systems to Strengthen Peripheral Vascular Portfolio

The acquisition will add intravascular lithotripsy (IVL) technology to Stryker’s offerings, designed to treat severely calcified arteries where hardened calcium deposits restrict blood flow and complicate vascular procedures.

Global medical technology company Stryker has announced a definitive agreement to acquire Amplitude Vascular Systems, a move aimed at strengthening its peripheral vascular portfolio with advanced revascularization technologies.

The acquisition will add intravascular lithotripsy (IVL) technology to Stryker’s offerings, designed to treat severely calcified arteries where hardened calcium deposits restrict blood flow and complicate vascular procedures.

Amplitude Vascular Systems has developed a technology that uses pulsed CO₂-generated pressure waves to fracture calcium deposits within blood vessels. The system is delivered through an IVL balloon catheter and is designed to improve catheter delivery, treatment speed, and procedural efficiency in complex vascular cases.

Stryker stated that the acquisition aligns with its strategy to build a comprehensive peripheral vascular platform focused on addressing unmet clinical needs in vascular disease treatment. The company develops medical and surgical equipment across orthopedics, neurotechnology, and related healthcare segments, along with training and support services.

According to Stryker CEO Kevin Lobo, combining Amplitude’s technology with Stryker’s scale and clinical expertise is expected to expand treatment options for physicians and improve care outcomes for patients with calcified peripheral arterial disease.

Both companies will continue operating independently until the transaction is completed. Financial terms of the acquisition were not disclosed.

Stryker, listed on the New York Stock Exchange under the ticker SYK, has a long-standing presence in the medical device industry. The company went public in 1979 and later transferred its listing to the NYSE in 1997.

The announcement comes as Stryker continues to navigate broader industry developments, including recent operational disruptions following a global cyberattack in March that impacted internal systems across its network.

The acquisition adds to ongoing consolidation trends in the global medical technology sector, particularly in specialized cardiovascular and vascular treatment technologies.

Stay tuned for more such updates on Digital Health News